Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II tasquinimod versus placebo in asymptomatic metastatic castration-resistant prostate cancer
2007-003470-26Phase 2Completed
- Sponsor
- Active Biotech AB
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in prostate cancer (PCa) comparing Tasquinimod with Placebo (2 arms). Primary endpoint: Proportion of patients with disease progression at 6 months. Started Aug 2007; status: completed.
02
Drugs
tasquinimod
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2007-003470-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003470-26.